
Quest Diagnostics announced a $500 million public offering of 5.000% senior notes due in 2036, expected to close on May 6, 2026. The company plans to use the proceeds for general corporate purposes, including repaying $500 million of 3.45% senior notes maturing in June 2026. This refinancing move helps Quest manage its debt profile and maintain financial flexibility. The offering is subject to customary closing conditions and is part of the company's ongoing capital management strategy.